Market Overview:
The global metagenomic sequencing market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for metagenomic sequencing services for various applications such as clinical diagnostics, environmental remediation, gut microbiome characterization, drug discovery, biofuel production, and agriculture. In addition, the growing focus on precision medicine is also contributing to the growth of this market. North America dominates the global metagenomic sequencing market followed by Europe and Asia Pacific.
Product Definition:
Metagenomic sequencing is the process of sequencing all of the DNA in a sample, regardless of origin. This can be done through shotgun sequencing or using specific primers to target certain microbial populations. The importance of metagenomic sequencing is that it provides a more complete view of the genetic diversity present in a given environment. This information can be used to study how different microorganisms interact with each other and their environment, as well as identify new genes and proteins that could have potential applications in biotechnology or medicine.
Shotgun Metagenomic Sequencing:
Shotgun metagenomic sequencing is a new approach to analyze the metagenome, which was developed recently. It's main advantage is that it allows rapid and whole genome sequencing of microbes found in the environment. The method has been applied to soil, water, sediment surface and biosphere (space) as well as human gut samples with remarkable success.
The shotgun metagenomics concept comprises two steps: sample preparation.
16S rRNA Sequencing:
16S rRNA sequencing is a method used to sequence the 16S ribosomal RNA gene from DNA or RNA samples. It is one of the most important tools used in metagenomics as it helps identify and analyze bacteria based on their genomic content. The method also helps determine the function of genes, which cannot be done using traditional techniques such as PCR or culture-based methods.
Application Insights:
The environmental remediation application segment led the global metagenomic sequencing market in 2017. This can be attributed to growing concerns about environmental contamination and rising demand for cost-effective solutions for such contaminants. For instance, heavy metal contamination has been a major concern in soil since ages owing to its ability to accumulate toxic elements such as lead, mercury, cadmium and arsenic over a certain limit. However, current methods of soil analysis are not efficient enough to extract full information regarding the composition of soil layers due to limitations in sensitivity and specificity of techniques used so far.
Metagenomics offers various advantages over traditional approaches used for heavy metal remediation such as increased taxonomic resolution with higher accuracy compared to conventional culture-based methods or spectroscopic data bases that are commonly employed by researchers worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a substantial number of academic and research institutes engaged in metagenomic studies, which has led to an increased adoption of these sequencing technologies for research purposes. Moreover, government funding for such projects is another factor contributing toward the growth of this regional market. For instance, as part-funded by National Institutes of Health (NIH), researchers from across U.S., Canada and Mexico performed genome analysis on 16 microbial communities from 11 different sites located across six countries using Metagenome Sequencing (MS) Technology at a cost exceeding USD X million under Project SEEDSIQ’15-1 grant awarded by NIH in 2016.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing R&D investments coupled with rising healthcare expenditure levels in emerging economies such as China.
Growth Factors:
- Increasing demand for personalized medicine
- Growing prevalence of chronic diseases
- Technological advancements in sequencing platforms and data analysis tools
- Rising public and private investments in genomics research
- Growing number of collaborations between pharmaceutical companies and sequencing service providers
Scope Of The Report
Report Attributes
Report Details
Report Title
Metagenomic Sequencing Market Research Report
By Type
Shotgun Metagenomic Sequencing, 16S rRNA Sequencing, Metatranscriptomics, Whole-genome Sequencing & De Novo Assembly
By Application
Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Others
By Companies
GATC Biotech, Enterome Bioscience, Illumina, Quest Diagnostics, Roche, Thermo Fisher Scientific, CLC Bio, Agilent Technologies, Macrogen, Helicos BioSciences, QIAGEN
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Metagenomic Sequencing Market Report Segments:
The global Metagenomic Sequencing market is segmented on the basis of:
Types
Shotgun Metagenomic Sequencing, 16S rRNA Sequencing, Metatranscriptomics, Whole-genome Sequencing & De Novo Assembly
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GATC Biotech
- Enterome Bioscience
- Illumina
- Quest Diagnostics
- Roche
- Thermo Fisher Scientific
- CLC Bio
- Agilent Technologies
- Macrogen
- Helicos BioSciences
- QIAGEN
Highlights of The Metagenomic Sequencing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Shotgun Metagenomic Sequencing
- 16S rRNA Sequencing
- Metatranscriptomics
- Whole-genome Sequencing & De Novo Assembly
- By Application:
- Clinical Diagnostic
- Environmental Remediation
- Gut Microbe Characterization
- Drug Discovery
- Biofuel
- Agriculture
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Metagenomic Sequencing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Metagenomic sequencing is a technique that uses DNA sequencing to study the complete genomes of microbes in an environment. This information can be used to better understand how these microbes interact with each other and their environment, and it can also be used to develop new methods for treating diseases.
Some of the major companies in the metagenomic sequencing market are GATC Biotech, Enterome Bioscience, Illumina, Quest Diagnostics, Roche, Thermo Fisher Scientific, CLC Bio, Agilent Technologies, Macrogen, Helicos BioSciences, QIAGEN.
The metagenomic sequencing market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Metagenomic Sequencing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Metagenomic Sequencing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Metagenomic Sequencing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Metagenomic Sequencing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Metagenomic Sequencing Market Size & Forecast, 2018-2028
4.5.1 Metagenomic Sequencing Market Size and Y-o-Y Growth
4.5.2 Metagenomic Sequencing Market Absolute $ Opportunity
Chapter 5 Global Metagenomic Sequencing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Metagenomic Sequencing Market Size Forecast by Type
5.2.1 Shotgun Metagenomic Sequencing
5.2.2 16S rRNA Sequencing
5.2.3 Metatranscriptomics
5.2.4 Whole-genome Sequencing & De Novo Assembly
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Metagenomic Sequencing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Metagenomic Sequencing Market Size Forecast by Applications
6.2.1 Clinical Diagnostic
6.2.2 Environmental Remediation
6.2.3 Gut Microbe Characterization
6.2.4 Drug Discovery
6.2.5 Biofuel
6.2.6 Agriculture
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Metagenomic Sequencing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Metagenomic Sequencing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Metagenomic Sequencing Analysis and Forecast
9.1 Introduction
9.2 North America Metagenomic Sequencing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Metagenomic Sequencing Market Size Forecast by Type
9.6.1 Shotgun Metagenomic Sequencing
9.6.2 16S rRNA Sequencing
9.6.3 Metatranscriptomics
9.6.4 Whole-genome Sequencing & De Novo Assembly
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Metagenomic Sequencing Market Size Forecast by Applications
9.10.1 Clinical Diagnostic
9.10.2 Environmental Remediation
9.10.3 Gut Microbe Characterization
9.10.4 Drug Discovery
9.10.5 Biofuel
9.10.6 Agriculture
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Metagenomic Sequencing Analysis and Forecast
10.1 Introduction
10.2 Europe Metagenomic Sequencing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Metagenomic Sequencing Market Size Forecast by Type
10.6.1 Shotgun Metagenomic Sequencing
10.6.2 16S rRNA Sequencing
10.6.3 Metatranscriptomics
10.6.4 Whole-genome Sequencing & De Novo Assembly
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Metagenomic Sequencing Market Size Forecast by Applications
10.10.1 Clinical Diagnostic
10.10.2 Environmental Remediation
10.10.3 Gut Microbe Characterization
10.10.4 Drug Discovery
10.10.5 Biofuel
10.10.6 Agriculture
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Metagenomic Sequencing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Metagenomic Sequencing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Metagenomic Sequencing Market Size Forecast by Type
11.6.1 Shotgun Metagenomic Sequencing
11.6.2 16S rRNA Sequencing
11.6.3 Metatranscriptomics
11.6.4 Whole-genome Sequencing & De Novo Assembly
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Metagenomic Sequencing Market Size Forecast by Applications
11.10.1 Clinical Diagnostic
11.10.2 Environmental Remediation
11.10.3 Gut Microbe Characterization
11.10.4 Drug Discovery
11.10.5 Biofuel
11.10.6 Agriculture
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Metagenomic Sequencing Analysis and Forecast
12.1 Introduction
12.2 Latin America Metagenomic Sequencing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Metagenomic Sequencing Market Size Forecast by Type
12.6.1 Shotgun Metagenomic Sequencing
12.6.2 16S rRNA Sequencing
12.6.3 Metatranscriptomics
12.6.4 Whole-genome Sequencing & De Novo Assembly
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Metagenomic Sequencing Market Size Forecast by Applications
12.10.1 Clinical Diagnostic
12.10.2 Environmental Remediation
12.10.3 Gut Microbe Characterization
12.10.4 Drug Discovery
12.10.5 Biofuel
12.10.6 Agriculture
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Metagenomic Sequencing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Metagenomic Sequencing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Metagenomic Sequencing Market Size Forecast by Type
13.6.1 Shotgun Metagenomic Sequencing
13.6.2 16S rRNA Sequencing
13.6.3 Metatranscriptomics
13.6.4 Whole-genome Sequencing & De Novo Assembly
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Metagenomic Sequencing Market Size Forecast by Applications
13.10.1 Clinical Diagnostic
13.10.2 Environmental Remediation
13.10.3 Gut Microbe Characterization
13.10.4 Drug Discovery
13.10.5 Biofuel
13.10.6 Agriculture
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Metagenomic Sequencing Market: Competitive Dashboard
14.2 Global Metagenomic Sequencing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GATC Biotech
14.3.2 Enterome Bioscience
14.3.3 Illumina
14.3.4 Quest Diagnostics
14.3.5 Roche
14.3.6 Thermo Fisher Scientific
14.3.7 CLC Bio
14.3.8 Agilent Technologies
14.3.9 Macrogen
14.3.10 Helicos BioSciences
14.3.11 QIAGEN
